Pharmacogenomics
Pharma regulators consult on drug development initiatives
July 13, 2011Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news
Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
